Omnicell - 23 Year Stock Price History | OMCL
Historical daily share price chart and data for Omnicell since 2001 adjusted for splits and dividends. The latest closing stock price for Omnicell as of April 26, 2024 is 27.86.
- The all-time high Omnicell stock closing price was 183.62 on November 23, 2021.
- The Omnicell 52-week high stock price is 77.14, which is 176.9% above the current share price.
- The Omnicell 52-week low stock price is 25.69, which is 7.8% below the current share price.
- The average Omnicell stock price for the last 52 weeks is 46.33.
| Omnicell Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 29.6393 | 37.3300 | 37.3300 | 26.1500 | 27.8600 | -25.96% |
| 2023 | 54.9378 | 51.5400 | 75.9400 | 29.2400 | 37.6300 | -25.37% |
| 2022 | 105.8126 | 180.5100 | 180.5100 | 46.2400 | 50.4200 | -72.06% |
| 2021 | 148.8128 | 119.2500 | 183.6200 | 117.7800 | 180.4400 | 50.34% |
| 2020 | 78.9133 | 81.5900 | 120.0200 | 55.4100 | 120.0200 | 46.87% |
| 2019 | 76.5606 | 59.9500 | 92.2100 | 58.8800 | 81.7200 | 33.44% |
| 2018 | 55.9629 | 49.5000 | 77.2300 | 40.1000 | 61.2400 | 26.27% |
| 2017 | 44.2153 | 34.4000 | 54.5000 | 32.1500 | 48.5000 | 43.07% |
| 2016 | 32.6380 | 29.1000 | 40.4000 | 25.4300 | 33.9000 | 9.07% |
| 2015 | 33.6857 | 32.2000 | 40.3900 | 26.5200 | 31.0800 | -6.16% |
| 2014 | 28.1718 | 25.0700 | 33.9600 | 25.0200 | 33.1200 | 29.73% |
| 2013 | 20.5197 | 15.3600 | 25.5900 | 14.9000 | 25.5300 | 71.69% |
| 2012 | 14.7252 | 16.7300 | 17.8500 | 12.7000 | 14.8700 | -9.99% |
| 2011 | 14.9752 | 14.5600 | 17.1100 | 12.9700 | 16.5200 | 14.33% |
| 2010 | 13.1030 | 11.9300 | 15.0500 | 11.1550 | 14.4500 | 23.61% |
| 2009 | 10.0900 | 12.8800 | 12.8800 | 6.7000 | 11.6900 | -4.26% |
| 2008 | 15.3948 | 26.9900 | 29.2900 | 8.3600 | 12.2100 | -54.66% |
| 2007 | 23.0314 | 18.3000 | 30.4000 | 16.5200 | 26.9300 | 44.55% |
| 2006 | 14.9477 | 12.0600 | 20.3500 | 10.4100 | 18.6300 | 55.90% |
| 2005 | 8.5260 | 10.7700 | 12.2900 | 6.1300 | 11.9500 | 8.64% |
| 2004 | 14.5299 | 16.3500 | 22.6400 | 8.9500 | 11.0000 | -32.10% |
| 2003 | 9.3975 | 3.0000 | 17.0800 | 2.4500 | 16.2000 | 511.32% |
| 2002 | 5.5959 | 9.0500 | 9.0500 | 1.4000 | 2.6500 | -70.22% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.279B | $1.147B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
| Inspire Medical Systems (INSP) | United States | $7.194B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.483B | 0.00 |
| Axonics (AXNX) | United States | $3.401B | 0.00 |
| 10x Genomics (TXG) | United States | $3.288B | 0.00 |
| Enovis (ENOV) | United States | $3.030B | 23.02 |
| Azenta (AZTA) | United States | $2.910B | 237.18 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.840B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.678B | 0.00 |
| Privia Health (PRVA) | United States | $2.167B | 96.11 |
| Schrodinger (SDGR) | United States | $1.733B | 0.00 |
| Phreesia (PHR) | United States | $1.162B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
| Standard BioTools (LAB) | United States | $0.708B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.337B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.153B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.141B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.141B | 0.00 |
| Augmedix (AUGX) | United States | $0.139B | 0.00 |
| Outset Medical (OM) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.03 |
| 111 (YI) | China | $0.086B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.048B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |